| 11096-26-7 Basic information More.. |
Product Name: | Erythropoietin | Synonyms: | Erythropoietin human,EPO;erythropoietin from human urine*approx 100 units;ANTI-ERYTHROPOIETIN(N-TERMINAL) antibody produced in rabbit;ANTI-ERYTHROPOIETIN(C-TERMINAL) antibody produced in rabbit;INN=Epoetin;ERYTHROPOIETIN RAT;EPO;Erythropoietin from rat | CAS: | 11096-26-7 | MF: | C22H22ClKN6O | MW: | 461.00098 | EINECS: | 234-317-2 | Mol File: | 11096-26-7.mol |  |
Use
Recombinant erythropoietin (EPO) is currently indicated for use only in anemia associated with renal transplant or end-stage renal disease. Widened indications for use in other forms of anemia, accompanied by price reductions as a result of keen competition, have been projected for EPO in the future.
- EPO
-
- 2025-08-31
- CAS:11096-26-7
- Min. Order:
- Purity: 0.99
- Supply Ability:
- EPO
-
- US $10.00 / box
- 2025-08-29
- CAS:11096-26-7
- Min. Order: 1box
- Purity: 99%
- Supply Ability: 100000box
|
11096-26-7
Recommend Suppliers |
|